Radioimmunoassay of detomidine, a new benzylimidazole drug with analgesic sedation properties.

The research article is about a new and sensitive method to measure levels of detomidine, a drug that provides analgesic sedation, using radioimmunoassay. This method also allows direct measurements from small serum and urine samples, providing important insights into the drug’s absorption and metabolism.

Objective

• The objective of the article was to develop a sensitive and specific method for measuring detomidine, a new benzylimidazole drug with sedative and analgesic properties. This was achieved by developing a radioimmunoassay. The researchers also conducted an experiment whereby this method was used to measure the levels of detomidine from samples of serum, urine, and tissue.

Procedure

• The researchers raised antibodies in rabbits against a conjugate of detomidine and bovine thyroglobulin in order to develop the radioimmunoassay.
• Subsequently, detomidine was iodinated with chloramine-T, a reagent often used for iodination. This modified detomidine acted as an immunoreactive marker, which was purified using cation exchange chromatography. This increased the sensitivity of the radioimmunoassay.
• The sensitivity of the developed assay was quite high, being able to measure detomidine concentrations as low as 1.6 fmol/tube. This sensitivity allowed the researchers to conduct direct measurements from smaller samples such as a minute serum and urine samples as well as tissue homogenates.

Experimental Study

• The researchers administered detomidine to one horse and two calves. Blood samples were taken and urine collected for 24 hours. The horse was then euthanized and tissue samples were taken for analyses.
• These samples were serially diluted and produced a linear displacement curve parallel to synthetic detomidine in the radioimmunoassay.
• A high-performance liquid chromatography (HPLC) study showed that the immunoreactivity of serum and tissue was unchanged detomidine. However, most of the immunoreactivity in the urine appeared to be due to an unidentified metabolite, suggesting that detomidine is metabolized in the body.